DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Bryson HM, Milne RJ, Chrisp P.
Selegiline: an appraisal of the basis of its pharmacoeconomic and quality-of-life benefits in Parkinson's disease.
Pharmacoeconomics 1992; 2: 118-136
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.